Thyroid News

Thyroid surgery-specific complications developed within 1 year of thyroid surgery in 12% of adults with differentiated or medullary thyroid cancer, and 6% developed general complications, according to published findings.

Treatment with radioactive iodine for differentiated thyroid carcinoma after primary surgical treatment was more effective for decreasing 5- and 10-year mortality than no radiation therapy or external beam radiation, published findings indicate.

In mothers with Graves’ disease, levels of anti-thyrotropin receptor antibodies predict the risk for fetal and neonatal thyroid dysfunction, according to findings from a retrospective study in France.

Adults with papillary thyroid microcarcinoma who underwent hemithyroidectomy may not need follow-up postoperative ultrasound imaging at 1- or 2-year intervals due to the low recurrence rates, according to published findings.

The risk for hip fracture may increase with low thyroid-stimulating hormone levels and high free thyroxine levels in euthyroid adults, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Free triiodothyronine levels at age 7 years were higher among boys and girls with a more advanced pubertal stage at age 13 years, whereas free thyroxine and thyroid-stimulating hormone levels were not associated with pubertal stage, according to published findings.

Parathyroid hormone levels in older women remained within the normal reference range as women aged, even with parathyroid hormone increases of up to 50% above baseline, researchers in Sweden reported.

AUSTIN, Texas — Online patient education materials addressing thyroid cancer are overwhelmingly written at a reading level beyond that recommended by national health care organizations, according to a speaker at the American Association of Clinical Endocrinologists’ Annual Scientific and Clinical Congress.

The U.S. Preventive Services Task Force announced it is recommending against screening for thyroid cancer in asymptomatic adults.

Women with papillary thyroid cancer during pregnancy can appropriately be treated with active surveillance and delayed thyroid surgery because there were no clinically relevant changes associated with papillary thyroid cancer during pregnancy, published data show.